The second-best performing fund in Canada focuses on an area of the markets that many consider to be risky: biotech. The Next Edge Biotch Plus Fund gained more than 36 per cent in Q1. Eden Rahim, portfolio manager and options strategist at Next Edge Capital, explains his winning strategy and discusses several companies that he believes have a lot of upside potential.